KEGG   PATHWAY: pvp05216
Entry
pvp05216                    Pathway                                
Name
Thyroid cancer - Pteropus vampyrus (large flying fox)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
pvp05216  Thyroid cancer
pvp05216

Disease
H00032  Thyroid cancer
Organism
Pteropus vampyrus (large flying fox) [GN:pvp]
Gene
105288383  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
105288953  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
105289326  MAPK1; mitogen-activated protein kinase 1 isoform X2 [KO:K04371] [EC:2.7.11.24]
105290030  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
105290328  CTNNB1; catenin beta-1 [KO:K02105]
105291226  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
105291480  TCF7L2; transcription factor 7-like 2 isoform X8 [KO:K04491]
105291659  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
105292561  MYC; myc proto-oncogene protein [KO:K04377]
105293004  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
105293567  TCF7; transcription factor 7 isoform X2 [KO:K02620]
105293770  [KO:K09288]
105294059  KRAS; GTPase KRas isoform X2 [KO:K07827]
105295054  TPR; nucleoprotein TPR [KO:K09291]
105295887  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
105296416  NTRK1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
105296457  TPM3; tropomyosin alpha-3 chain [KO:K09290]
105296550  NRAS; GTPase NRas isoform X1 [KO:K07828]
105298541  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
105299024  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
105300252  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
105300424  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
105300975  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
105301000  [KO:K14021]
105301762  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
105302177  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
105302941  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
105303986  PAX8; paired box protein Pax-8 isoform X2 [KO:K09293]
105304566  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
105305756  CDH1; cadherin-1 isoform X1 [KO:K05689]
105305933  HRAS; GTPase HRas isoform X1 [KO:K02833]
105306744  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
105307128  [KO:K04503]
105307139  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
105309193  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X4 [KO:K05126] [EC:2.7.10.1]
105309827  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
105311618  TFG; protein TFG isoform X3 [KO:K09292]
111728746  [KO:K14021]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
pvp03320  PPAR signaling pathway
pvp04010  MAPK signaling pathway
pvp04115  p53 signaling pathway
pvp04310  Wnt signaling pathway
pvp04520  Adherens junction
KO pathway
ko05216   

DBGET integrated database retrieval system